Prestorage leukofiltration of whole blood and SAGM blood prevents extracellular bioactive substance accumulation

Inflammation Research

Volumn 48, Issue 7, 1999, Pages 363-368

  Mynster, T ^a   Dybkjaer E ^a   Reimert, C M ^b   Pedersen, A N ^c   Ostergaard K ^a   Vangsgaard, K ^a   Nielsen, H J ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

^c FINSEN LABORATORY   (Denmark)

Author keywords

Eosinophil cationic protein; Histamine; Myeloperoxidase; Plasminogen activator inhibitor 1; Prestorage leukofiltration

Indexed keywords

ADENINE; EOSINOPHIL CATIONIC PROTEIN; GLUCOSE; HISTAMINE; MANNITOL; MYELOPEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SODIUM CHLORIDE;

ARTICLE; BLOOD; BLOOD DONOR; BLOOD STORAGE; CELL SUSPENSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FILTRATION; HUMAN; HUMAN CELL; LEUKOCYTE; RADIOIMMUNOASSAY; TEMPERATURE; THROMBOCYTE; TIME;

BLOOD PRESERVATION; BLOOD PROTEINS; EOSINOPHIL GRANULE PROTEINS; FILTRATION; HISTAMINE; HUMANS; LEUKOCYTES; PEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTOPERATIVE COMPLICATIONS; RIBONUCLEASES; TIME FACTORS;

EID: 0032802239     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050473     Document Type: Article

References (33)

1. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med 1994; 118: 371-9.
2. Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995; 82: 582-7.
3. Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79: 513-6.
4. Jensen LS, Hokland M, Nielsen HJ. A randomised controlled study of the effect of bedside leukocyte depletion on the immuno-suppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1996; 83: 973-7.
5. Houbiers JGA, Brand A, van de Watering LMG, Hermans J, Verwey PJM, Bijnen AB, et al. Randomised controlled trial comparing transfusion of leukocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344: 573-8.
6. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leukocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348: 841-5.
7. Nielsen HJ. The effect of histamine type-2 receptor antagonists on posttraumatic immune competence. Dan Med Bull 1995; 42:162-74.
8. Norrby K, Woolley D. Role of mast cells in mitogenesis and angiogenesis in normal tissue and tumor tissue. Adv Biosci 1993; 89: 71-116.
9. Babior BM. Oxidants from phagocytes: agents of defence and destruction. Blood 1984; 64: 959-66.
10. Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cell. Kidney Int 1992; 41: 375-83.
11. Peterson CBG, Skoog V, Venge P. Human eosinophil cationic proteins (ECP and EPX) and their suppressive effects on lymphocyte proliferation. Immunobiology 1986; 171: 1-13.
12. Reimert CM, Poulsen LK, Bindslev-Jensen C, Kharazmi A, Bendtzen K. Measurement of eosinophil cationic protein (ECP) and eosinphil protein X/eosinophil derived neurotoxin (EPX/ EDN). J Immunol Methods 1993; 166: 183-90.
13. van Goor H, deGraaf JS, Grond J, Sluiter WJ, van der Meer J, Bom VJ, et al. Fibrinolytic activity in the abdominal cavity of rats with faecal peritonitis. Br J Surg 1994; 81: 1046-9.
14. Pappot H, Gardsvoll H, Romer J, Pedersen AN, Grondahl-Hansen J, Pyke C, et al. Plasminogen activator inhibitor type 1 in cancer. Therapeutic and prognostic implications. Biol Chem Hoppe Seyler 1995; 376: 259-67.
15. Nielsen HJ, Edvardsen L, Vangsgaard K, Dybkjær E, Skov PS. Time-dependent histamine release from stored human blood products. Br J Surg 1996; 83: 259-62.
16. Nielsen HJ, Reimert CM, Pedersen AN, Brünner N, Edvardsen L, Dybkjær E, et al. Time-dependent, spontaneous release of leukocyte and platelet derived bioactive substances from stored human blood. Transfusion 1997; 36: 960-5.
17. Mynster T, Dybkjæer E, Kronborg G, Nielsen HJ. Immunomodulating effect of blood transfusion. Is storage time important? Vox Sang 1998; 74: 176-81.
18. Purdy FR, Tweeddale MG, Merrick PM. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 1997; 44: 1256-61.
19. Nielsen HJ, Skov F, Dybkjær E, Reimert CM, Pedersen AN, Brünner N, et al. Leukocyte and platelet-derived bioactive substances in stored blood: effect of prestorage leukocyte filtration. Eur J Haematol 1997; 58: 273-8.
20. Beaujean F, Segier JM, Le Forestier C, Duedari N. Leukocyte depletion of red cell concentrates by filtration: influence of blood product temperature [letter]. Vox Sang 1992; 62: 242-3.
21. Glaser A, Erpenbeck T, Böck M, Heim M, Mempel W. Effectiveness of white cell reduction with respect to blood storage time [letter]. Transfusion 1993; 33: 536-7.
22. Högman CF, Gong J, Eriksson L, Hambraeus A, Johansson CS. White cells protects donor blood against bacterial contamination. Transfusion 1991; 31: 620-6.
23. Reimert CM, Venge P, Kharazmi A, Bendtzen K. Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J Immunol Methods 1991; 138: 285-93.
24. Grondahl-Hansen J, Christensen IJ, Rosenquist C, Brunner N, Mouridsen HT, Dano K, et al. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 1993; 53: 2513-21.
25. Alcorta I, Pereira A, Sanz C, Terol MJ, Ordinas A. Influence of the red blood cell preparation method on the efficacy of a leukocyte reduction filter. Vox Sang 1996; 71: 78-83.
26. Nielsen HJ, Hammer JH, Krarup A, Nielsen LM, Reimert CM, Pedersen AN, et al. Prestorage filtration of blood compounds may reduce accumulation of bioactive substances in burn trauma patients. Burns 1999; 25: 162-170.
27. Hammer JH, Mynster T, Reimert CM, Pedersen AN, Dybkjæer E, Alsbjørn B, et al. Effect of heating on extracellular bioactive substances in stored human blood: In vitro study. J Trauma 1997; 43: 799-803.
28. Brecher ME, Pineda AA, Torloni AS, Harbaugh CA, Emery RL, Moore SB, et al. Prestorage leukocyte depletion: Effect on leukocyte and platelet metabolites, erythrocyte lysis, metabolism, and in vivo survival. Sem Hematol 1991; 28 Suppl 5: 3-9.
29. Jeter EK, Spivey MA. Noninfectous complications of blood transfusion. Hematol Oncol Clin North Am 1995; 9: 187-204.
30. Heddle NM, Klama LN, Griffith L, Roberts R, Shukla G, Kelton JG. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993; 33: 794-7.
31. Frewin DB, Jonsson JR, Frewin CR, Russell WJ, Russell MW, Davis KG, et al. Influence of blood storage time and plasma histamine levels on the pattern of transfusion reactions. Vox Sang 1989; 56: 243-6.
32. Mynster T, Nielsen HJ. Clinical consequence of blood storage time. Vox Sang 1998; 74 Suppl 1: 82.
33. Vamvakas EC, Carven JH. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery. Effect of the length of storage of transfused red cells. Transfusion 1998; 10 Suppl: S283.